Role of Kupffer cells in lung injury in rats administered endotoxin 1. 2005

Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
First Department of Surgery, University of Yamanashi, Yamanashi, Japan. hkouno@res.yamanashi-med.ac.jp

The purpose of this study was to investigate the regulation of lung macrophages (Muvarphis) by Kupffer cells (KCs) in lung injury caused by endotoxemia. Phenotypic differences in tissue Muvarphis were also investigated. Muvarphis were isolated from gadolinium chloride (GdCl(3))- or saline-treated rats 2 h after saline or lipopolysaccharide (LPS) administration. Furthermore, rats were given GdCl(3) 24 h prior to LPS administration, and survival rate was assessed for 24 h. Moreover, lung edema was assessed 9 h after LPS injection. Expression of inflammatory mediators was measured in the liver and lung. KCs were divided into three subpopulations based on size and phagocytosis. The expression of TNF-alpha and MIP-2 was greater in the small KCs and lung Muvarphis, while the expression of IL-6, IL-10, and MCP-1 was greater in the large and intermediate KCs. GdCl(3) eliminated ED2-positive large KCs and did not have any effect on the lung Muvarphis. The number of ED1-positive KCs increased significantly in both organs after LPS challenge and was reduced by GdCl(3). The population of ED2-positive KCs did not change following LPS administration. GdCl(3) completely prevented increases in lung microvascular permeability and mortality after LPS infusion. After LPS administration, expression of TNF-alpha and IL-6 increased rapidly and then decreased gradually in both organs. GdCl(3) inhibited these increases in the liver significantly and enhanced the expression of MCP-1 and IL-10 in the lung 9 h after LPS administration. Thus, the heterogeneous response of KCs to endotoxin leads to production of certain cytokines and chemokines that affect lung function.

UI MeSH Term Description Entries
D007728 Kupffer Cells Specialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood and dispose of worn out red blood cells. Kupffer Cell,Cell, Kupffer,Cells, Kupffer
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D011654 Pulmonary Edema Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening. Wet Lung,Edema, Pulmonary,Edemas, Pulmonary,Pulmonary Edemas,Lung, Wet,Lungs, Wet,Wet Lungs
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell

Related Publications

Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
January 2006, World journal of gastroenterology,
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
May 1989, Journal of applied physiology (Bethesda, Md. : 1985),
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
January 1999, Pulmonary pharmacology & therapeutics,
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
January 1994, Surgery today,
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
October 1998, The American journal of physiology,
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
February 1994, American journal of respiratory cell and molecular biology,
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
July 1996, Hepatology (Baltimore, Md.),
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
January 1990, Advances in experimental medicine and biology,
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
February 2009, Critical care medicine,
Hiroshi Kono, and Hideki Fujii, and Hidetake Amemiya, and Masami Asakawa, and Yu Hirai, and Akira Maki, and Masato Tsuchiya, and Masanori Matsuda, and Masayuki Yamamoto
July 2008, American journal of surgery,
Copied contents to your clipboard!